Literature DB >> 2488377

The peak concentration hypothesis: a urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis.

P R Keshaviah1, K D Nolph, J C Van Stone.   

Abstract

The KT/V urea index (K, clearance; T, treatment time; V, volume of urea distribution) has become an established index of hemodialysis (HD) adequacy, values of KT/V less than 0.8 being associated with overt uremic toxicity. For the typical continuous ambulatory peritoneal dialysis (CAPD) regimen of 4 X 2 L exchanges/day, the equivalent KT/V approximately 0.6. Paradoxically, overt uremic toxicity is not commonly observed in CAPD patients with this typical therapy prescription. Application of the urea kinetic model demonstrates that HD and CAPD have the same time-averaged urea concentration at the same KT/V. However, as HD is an intermittent therapy, the urea concentration in HD exceeds the time-averaged concentration for about half the hours in the week. If uremic toxicity is related to the peak rather than the time-averaged urea concentration, a higher KT/V would be required in HD to achieve a peak concentration at or below the steady-state CAPD concentration. This peak concentration hypothesis predicts, based on the results of the National Cooperative Dialysis Study, that underdialysis with CAPD would occur at KT/V less than 0.4 for a protein intake of 1.1 gm/kg/day.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2488377

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  17 in total

1.  Outcomes after the long interdialytic break: implications for the dialytic prescription.

Authors:  Jennifer E Flythe; Eduardo Lacson
Journal:  Semin Dial       Date:  2012 Jan-Feb       Impact factor: 3.455

Review 2.  Dosing of renal replacement therapy in acute kidney injury.

Authors:  Anitha Vijayan; Paul M Palevsky
Journal:  Am J Kidney Dis       Date:  2012-01-11       Impact factor: 8.860

Review 3.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

Review 4.  Dialysis therapy in end-stage renal disease.

Authors:  A Kalia
Journal:  Indian J Pediatr       Date:  1999 Mar-Apr       Impact factor: 1.967

Review 5.  Peritoneal dialysis prescription during the third trimester of pregnancy.

Authors:  Rodolfo R Batarse; Ralph M Steiger; Steven Guest
Journal:  Perit Dial Int       Date:  2014-04-07       Impact factor: 1.756

6.  Design of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure.

Authors:  Paul M Palevsky; Theresa O'Connor; Jane Hongyuan Zhang; Robert A Star; Mark W Smith
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

Review 7.  Beyond Kt/V: redefining adequacy of dialysis in the 21st century.

Authors:  Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

8.  The MDRD equation predicts peritoneal dialysis-delivered creatinine clearances from serum creatinine.

Authors:  Nitin Khosla; Robert W Steiner
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

9.  Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury.

Authors:  Sergio Vesconi; Dinna N Cruz; Roberto Fumagalli; Detlef Kindgen-Milles; Gianpaola Monti; Anibal Marinho; Filippo Mariano; Marco Formica; Mariano Marchesi; Robert René; Sergio Livigni; Claudio Ronco
Journal:  Crit Care       Date:  2009-04-15       Impact factor: 9.097

10.  Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study.

Authors:  Paul M Palevsky; Theresa Z O'Connor; Glenn M Chertow; Susan T Crowley; Jane Hongyuan Zhang; John A Kellum
Journal:  Crit Care       Date:  2009-08-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.